Ke Li

ORCID: 0000-0001-5634-6308
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinoids in leukemia and cellular processes
  • Histone Deacetylase Inhibitors Research
  • T-cell and Retrovirus Studies
  • Autophagy in Disease and Therapy
  • Endoplasmic Reticulum Stress and Disease
  • Immune Cell Function and Interaction
  • Acute Myeloid Leukemia Research
  • Ubiquitin and proteasome pathways
  • Cancer Cells and Metastasis
  • CAR-T cell therapy research
  • Lymphoma Diagnosis and Treatment
  • Protein Degradation and Inhibitors
  • Cancer, Hypoxia, and Metabolism
  • Cancer Immunotherapy and Biomarkers
  • Peptidase Inhibition and Analysis
  • Pancreatic function and diabetes
  • Immunotherapy and Immune Responses
  • Acute Lymphoblastic Leukemia research
  • Cancer-related gene regulation
  • Hedgehog Signaling Pathway Studies
  • Lung Cancer Research Studies
  • Colorectal Cancer Screening and Detection
  • Medical Imaging and Pathology Studies
  • RNA regulation and disease
  • Immune Response and Inflammation

Chinese Academy of Medical Sciences & Peking Union Medical College
2013-2025

Nanchang University
2024

Peking Union Medical College Hospital
2024

University of Science and Technology of China
2024

Chinese PLA General Hospital
2024

Guangzhou Center for Disease Control and Prevention
2023

Antibiotic (Bulgaria)
2022

Xuzhou Medical College
2022

Shaanxi Normal University
2021

Central South University
2020

Abstract The existence of breast cancer stem cells (BCSCs) is a major reason underlying metastasis and recurrence after chemotherapy radiotherapy. Targeting BCSCs may ameliorate relapse therapy resistance. Here we report that expression the pseudokinase Tribble 3 (TRIB3) positively associates with stemness progression. Elevated TRIB3 supports by interacting AKT to interfere FOXO1-AKT interaction suppress FOXO1 phosphorylation, ubiquitination, degradation E3 ligases SKP2 NEDD4L. accumulated...

10.1038/s41467-019-13700-6 article EN cc-by Nature Communications 2019-12-16

High CD8+ T cell infiltration in colorectal cancer (CRC) should suggest a favorable prognosis and satisfactory response to immunotherapy; however, the vast majority of patients with CRC do not benefit from immunotherapy due poor infiltration. Therefore, better understanding mechanisms for exclusion tumors is needed. Tribbles homolog 3 (TRIB3) has been implicated as an oncoprotein, but its role regulating antitumor immune responses defined. Here, we demonstrated that TRIB3 inhibits various...

10.1126/scitranslmed.abf0992 article EN Science Translational Medicine 2022-01-05

Impaired macroautophagy/autophagy is involved in the pathogenesis of hepatic fibrosis. However, how aberrant autophagy promotes fibrosis far from understood. Here, we aimed to define a previously unrevealed pro-fibrotic mechanism for stress protein TRIB3 (tribbles pseudokinase 3)-mediated dysfunction. Human fibrotic liver tissues were obtained patients with cirrhosis who underwent an open surgical repair process. The functional implications evaluated mouse models induced by bile duct...

10.1080/15548627.2019.1635383 article EN Autophagy 2019-07-09

Abstract High expression or aberrant activation of epidermal growth factor receptor (EGFR) is related to tumor progression and therapy resistance across cancer types, including non-small cell lung (NSCLC). EGFR tyrosine kinase inhibitors (TKIs) are first-line for NSCLC. However, patients eventually deteriorate after inevitable acquisition TKI-resistant mutations, highlighting the need therapeutics with alternative mechanisms action. Here, we report that elevated tribbles pseudokinase 3...

10.1038/s41467-020-17385-0 article EN cc-by Nature Communications 2020-07-21

CD8 + T cell activation leads to the rapid proliferation and differentiation of effector cells (T effs ), which mediate antitumor immunity. Although aerobic glycolysis is preferentially activated in , mechanisms that regulate glucose uptake low-glucose acidic tumor microenvironment (TME) remain poorly understood. Here, we report abundance transporter GLUT10 increased during Specifically, deficiency inhibited uptake, glycolysis, efficiency tumor-infiltrating cells. Supplementation with alone...

10.1126/scitranslmed.adk7399 article EN Science Translational Medicine 2024-08-28

The MEK-ERK signaling pathway and autophagy play an important role for enterovirus71(EV71) replication. Inhibition of is shown to impair EV71 Berberine (BBR), isoquinoline alkaloid isolated from Berberis vulgaris L., has been reported have ability regulate this autophagy. Herein, we want determine whether berberine can inhibit infection by downregulating the MEK/ERK autophagy.The antiviral effect was determined cytopathic (CPE) assay, western blotting assay qRT-PCR assay. mechanism BBR...

10.1186/s12985-016-0674-4 article EN cc-by Virology Journal 2017-01-11

Abstract Developing novel drugs that can abrogate the growth and metastasis of malignant tumors is a major challenge for cancer researchers. Here we describe synthetic retinoid, namely WYC-209, which inhibits proliferation murine melanoma tumor-repopulating cells (TRCs), known to resist conventional drug treatment, with an IC 50 0.19 μM in dose-dependent manner. WYC-209 also TRCs human melanoma, lung cancer, ovarian breast culture. Interestingly, treated fail resume even after washout....

10.1038/s41467-018-03877-7 article EN cc-by Nature Communications 2018-04-11

Abstract In this study, the effects of Baicalin on hyperglycemia-induced cardiovascular malformation during embryo development were investigated. Using early chick embryos, an optimal concentration (6 μM) was identified which could prevent embryos. Hyperglycemia-enhanced cell apoptosis reduced in embryos and HUVECs presence Baicalin. Hyperglycemia-induced excessive ROS production inhibited when administered. Analyses SOD, GSH-Px, MQAE GABAA suggested plays antioxidant role possibly through...

10.1038/s41419-018-0318-2 article EN cc-by Cell Death and Disease 2018-02-14

Abstract Dysregulated hematopoietic niches remodeled by leukemia cells lead to imbalances in immunological mediators that support leukemogenesis and drug resistance. Targeting immune may ameliorate disease progression tyrosine kinase inhibitor (TKI) resistance Philadelphia chromosome-positive B-ALL (Ph + B-ALL). Here, we show T helper type 17 (Th17) IL-17A expression are distinctively elevated Ph patients. promotes the of B-ALL. Mechanistically, activates BCR-ABL, IL6/JAK/STAT3, NF-kB...

10.1038/s41467-023-44270-3 article EN cc-by Nature Communications 2024-01-03

Enterovirus A71 (EV-A71) is the main pathogen causing hand, foot and mouth disease (HFMD) in children occasionally associated with neurological diseases such as aseptic meningitis, brainstem encephalitis (BE) acute flaccid paralysis. We report here that cellular pseudokinase tribbles 3 (TRIB3) facilitates infection of EV-A71 via dual mechanisms. In one TRIB3 maintains metabolic stability scavenger receptor class B member 2 (SCARB2),

10.1080/22221751.2024.2307514 article EN cc-by-nc Emerging Microbes & Infections 2024-01-19

Cell-penetrating peptides provide a unique platform to create new generation of cancer therapeutics with enhanced efficacy and diminished toxicity. In our study, expression toll-like receptor 2 (TLR2) was observed in acute myeloid leukemia (AML) cells. Screening phage display peptide library using Biopanning Rapid Analysis Selective Interactive Ligands (BRASIL) identified TLR2-binding motif, Pep2. We show that the motif targeted penetrated into cells TLR2-dependent manner. Moreover,...

10.1002/ijc.28382 article EN International Journal of Cancer 2013-07-13

Background Heart failure (HF) is one of the most significant causes morbidity and mortality for cardiovascular risk population. We found previously that extracellular HSP70 (heat shock protein) an important trigger in cardiac hypertrophy fibrosis, which are associated with development heart dysfunction. However, potential role response to HF whether it could be a target therapy remain unknown. Methods Results An mouse model was generated by single IP injection doxorubicin at dose 15 mg/kg....

10.1161/jaha.119.012338 article EN cc-by-nc-nd Journal of the American Heart Association 2019-10-02

Acute myeloid leukemia (AML) featuring retinoic acid receptor-gamma (RARG) rearrangements exhibits morphological features resembling those of acute promyelocytic but is associated with drug resistance and poor clinical outcomes. However, the mechanisms underlying role RARG fusions in leukemogenesis remain elusive. Here, we show that disrupt differentiation promote proliferation self-renewal hematopoietic stem progenitor cells (HSPCs) by upregulating BCL2 ATF3. overexpression leads to...

10.1038/s41467-024-55047-7 article EN cc-by-nc-nd Nature Communications 2025-01-13

Colorectal cancer (CRC) is the third most common in China. The incidence of CRC has been increasing recent years. aim this study was to explore trends and age distribution by subsite Guangzhou between 2000 2011. A total 22,432 incident cases 2011 from Cancer Registry were identified. Crude age-standardized rates (ASRs), using Segi's world standard population, calculated for subsites. trend analyzed annual percentage change (APC) JoinPoint software. crude increased significantly 23.4/105...

10.1186/s40880-015-0026-6 article EN cc-by Chinese Journal of Cancer 2015-08-05

CSCs (Cancer stem cells) with distinct metabolic features are considered to cause HCC (hepatocellular carcinoma) initiation, metastasis and therapeutic resistance. Here, we perform a gene CRISPR/Cas9 knockout library screen in tumorspheres derived from cells find that deletion of SCARB2 suppresses the cancer cell-like properties cells. Knockout Scarb2 hepatocytes attenuates initiation progression both MYC-driven DEN (diethylnitrosamine)-induced mouse models. Mechanistically, binding MYC...

10.1038/s41467-023-41593-z article EN cc-by Nature Communications 2023-09-22

Most basal-like breast cancers (BLBCs) are triple-negative (TNBCs), which have the worst prognosis and distant metastasis-free survival among cancer subtypes. Now, no targeted therapies available for patients with BLBC due to lack of reliable effective molecular targets. Here, we performed tissue microarray-based immunohistochemical analysis showed that Faciogenital Dysplasia 5 (FGD5) abundance is associated poor in BLBCs. FGD5 deletion decreased proliferation, invasion, tumorsphere...

10.1126/scitranslmed.abb2914 article EN Science Translational Medicine 2021-03-24

Pulmonary fibrosis (PF) is a chronic, progressive, fatal interstitial lung disease with limited available therapeutic strategies. We recently reported that the protein kinase glycogen synthase kinase-3β (GSK-3β) interacts and inactivates ubiquitin-editing enzyme A20 to suppress degradation of transcription factor CCAAT/enhancer-binding beta (C/EBPβ) in alveolar macrophages (AMs), resulting profibrotic phenotype AMs promoting development PF. Here, we showed chronic injury upregulated stress...

10.1016/j.apsb.2021.06.017 article EN cc-by-nc-nd Acta Pharmaceutica Sinica B 2021-07-07

Pulmonary fibrosis (PF) is the pathological structure of incurable fibroproliferative lung diseases that are attributed to repeated injury-caused failure alveolar regeneration (LAR). Here, we report repetitive damage results in a progressive accumulation transcriptional repressor SLUG epithelial type II cells (AEC2s). The abnormal increased inhibits AEC2s from self-renewal and differentiation into I (AEC1s). We found elevated represses expression phosphate transporter SLC34A2 AEC2s, which...

10.1016/j.apsb.2023.01.008 article EN cc-by-nc-nd Acta Pharmaceutica Sinica B 2023-01-11

Peripheral T-cell lymphoma (PTCL) is a heterogeneous and aggressive disease with poor prognosis. Histone deacetylase (HDAC) inhibitors have shown inhibitory effects on PTCL. A better understanding of the therapeutic mechanism underlying HDAC could help improve treatment strategies. Herein, we found that high expression HDAC3 associated prognosis in inhibition suppressed growth immunocompetent mice but not immunodeficient mice. deletion delayed progression lymphoma, reduced burden thymus,...

10.1158/0008-5472.can-23-3250 article EN Cancer Research 2024-05-08
Coming Soon ...